What is META's current stock price?

As of now, META is trading at $661.46, with a daily change of -1.31%.

What are the risks associated with META stock?

META has Low, risk level based on volatility, sector strength, volume, investor confidence and outlook.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

META Stock Analysis & IQ Rating | Meta Platforms

META META Badge

Meta Platforms

$661.46

-$8.75 | -1.31%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$796.25

MKT CAP

$1.67T

52W Low

$479.8

VOL

$15.46M

P/E Ratio

22.86

AVG VOL

$15.79M

RSI

TREND

Sideways

META Stock IQ

Login to see Meta Platforms (META) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

META Target Price

Login to display

Strengths

META Rewards

Earnings are forecast to grow

META Rewards

Upgraded on attractively valued

META Rewards

Trading below its fair value

META Rewards

Outperform the market

META Price Performance

$653.06 (+1.29%)

$627.08 (+5.48%)

$764.7 (-13.50%)

$668.13 (-1.00%)

1year

6month

3month

1month

META Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

META Analysts Opinion

META Analysts opinion is positive and also has improved from the past 3 months

META Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

86%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

83%

89%

META Street Sentiment

META Street Sentiment is extremely bullish and have positive views on the near-term outlook

META Risk Level

META has Low risk level

Risks Indicators

Beta greater than 1.0

Investors losing confidence

Low

LOW

HIGH

META Performance Sentiment

Sentiments overview associated with events and the stock performance

86%

13%

Positive

Negative

304 out of 352
events present

46 out of 352
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support
Price

$670.21

Resistance
Price

$604.12

Current Price Range

$738.31

Show methods +

Analyst Consensus

Recent Upgrades and Downgrades

95%

Buy

Hold

Sell

Consensus Rating

STRONG BUY

21

1

0

Date

Action

Rating

Firm

Feb 05, 2026

Price Target Raised

Buy

Freedom Capital

Jan 30, 2026

Reiterate

Buy

Stifel

Jan 26, 2026

Upgrade

Buy

Roth

Jan 21, 2026

Price Target Raised

Buy

BofA

Jan 21, 2026

Reiterate

Buy

Truist Securities

META Latest Analysis +

Whats Going On With Meta Platforms Stock Thursday?. META) stock is trading down in Thursday’.s regular trading extending losses to 9.13% over the past five days.The decline appears connected to broader weakness across major indexes. The Nasdaq-100 fell 1.32% to 24561 while the S&.P 500 dropped 1.04% to 6810.Meta’.s current weakness contrasts with its post-earnings performance following fourth-quarter results released January 29. Shares surged 9.24% to $730.50 that day after the comp

Thu Feb 5, 2026

$670.21 | +0.18%

Momentum

Will Meta Platforms Stock Plunge in 2026? 1 Warning and 1 Reason to Be Optimistic.. Key PointsMeta shares dipped in 2018 and 2022 so a fall in 2026 would line up with recent trends.

Thu Feb 5, 2026

$670.21 | +0.18%

Momentum

FDA Accepts Summit Therapeutics (SMMT) BLA For Ivonescimab In NSCLC With November 14 PDUFA Date Following Positive Phase III Data. Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the stocks that should double by 2030. On January 29 Summit Therapeutics announced that the US FDA accepted its BLA (Biologics License Application) for ivonescimab used in combination with chemotherapy. The treatment targets patients with EGFR-mutated locally advanced or metastatic non-squamous NSCLC (non-small cell lu

Thu Feb 5, 2026

$670.21 | +0.18%

Activity

Meta Platforms (META) Reports Strong Quarterly Results on Advertising Momentum. Meta Platforms Inc. (NASDAQ:META) is one of the 10 Buzzing AI Stocks on Market Radar. On February 3 Freedom Capital Markets analyst Saken Ismailov raised the price target on the stock to $825.00 (from $800.00) while maintaining a Buy rating. The rating affirmation follows Metas fourth-quarter 2025 results. The tech giant reported earnings that topped estimates and [….]

Thu Feb 5, 2026

$670.21 | +0.18%

Earnings

Rating

Despite Nearing a $2 Trillion Market Cap Meta Platforms Just Missed a Golden Opportunity. Key PointsThe Magnificent Seven -- led by Facebook parent Meta Platforms in 2026 -- have done most of the heavy lifting on Wall Street.

Thu Feb 5, 2026

$670.21 | +0.18%

Potential

Notable Wednesday Option Activity: META HOOD APP. Among the underlying components of the S&.P 500 index we saw noteworthy options trading volume today in Meta Platforms Inc (Symbol: META) where a total of 353162 contracts have traded so far representing approximately 35.3 million underlying shares. That amounts to about

Wed Feb 4, 2026

$668.99 | -3.28%

Momentum

Too Much Artificial Intelligence (AI) Capex? Not for Meta CEO Mark Zuckerberg Who Is Full Steam Ahead Much to the Markets Delight. Key PointsMeta Platforms recently unveiled capex guidance that was higher than Wall Street analysts expected.

Wed Feb 4, 2026

$668.99 | -3.28%

Momentum

Organon Launches Third Edition of Womens Health Accelerator Program Across Middle East Turkey &. Africa. Empowering digital health start-ups in family planning fertility and wellness – and addressing critical unmet needs across the META region DUBAI UAE Feb. 4 2026 /PRNewswire/ -- Organon has launched the third edition of its Womens Health Accelerator Program expanding it to include...

Wed Feb 4, 2026

$668.99 | -3.28%

Activity

Should Corning Be in Your Portfolio Post Strong Q4 Earnings?. GLWs Q4 beat AI data center momentum and big Meta deal lift Optical Communications but display and auto weakness temper the outlook.

Tue Feb 3, 2026

$691.70 | -2.08%

Earnings

LGND: New Year Program Updates. By In the wake of the December analyst day Ligand Pharmaceuticals Inc.s (NASDAQ:LGND) partners have seen meaningful activity with another acquisition for Pelthos a delay in Filsparis Target Action Date a drug application acceptance for Ohtuvayre in China positive results for Palvellas portfolio and a strategic collaboration for BOT/ BAL. Ligand also made an investment in Athira (now LeonaBio) as part of a consortium in support of the acquisition of lasofoxifene. I

Tue Feb 3, 2026

$691.70 | -2.08%

Activity

Runners Also Watch

Close Price

Change

GOOG

Google

323.10

-2.48%

PINS

19.60

+1.45%

WB

Weibo

10.19

+2.31%

TRIP

TripAdvisor

12.77

+2.74%

BIDU

Baidu

145.93

+5.02%

FAQ About META Stock Insights

What is META current stock price?

What are META stock strengths?

What is META Risk Level?

What is META market cap and volume?

What is META current Stock IQ?

Should I buy META stock right now?

Is META a Strong Buy right now?

What does a 'Strong Buy' rating mean for META?

What does a 'Strong Sell' rating mean for META?

What factors influence META's Stock IQ?

Explore our META Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored META Stock Strategies
Effective Risk Management

FIND US ON

Receive our META Daily Alerts

Join over 5,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

META META Badge

Meta Platforms

Set Alerts

Current Price

$661.46

-$8.75 | -1.31%

52W High

$796.25

MKT CAP

$1.67T

52W Low

$479.8

VOL

$15.46M

P/E Ratio

22.86

AVG VOL

$15.79M

RSI

TREND

Sideways

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Runners Also Watch

Symbol

Close

Change

GOOG

Google

323.10

-2.48%

PINS

19.60

+1.45%

WB

Weibo

10.19

+2.31%

TRIP

TripAdvisor

12.77

+2.74%

BIDU

Baidu

145.93

+5.02%

META Price Performance

$653.06 (+1.29%)

$627.08 (+5.48%)

$764.7 (-13.50%)

$668.13 (-1.00%)

1year

6month

3month

1month

META Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

META Analysts Opinion

META Analysts opinion is positive and also has improved from the past 3 months

META Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

86%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

83%

89%

META Street Sentiment

META Street Sentiment is extremely bullish and have positive views on the near-term outlook

META Risk Level

META has Low risk level

Risks Indicators

Beta greater than 1.0

Investors losing confidence

Low

LOW

HIGH

META Performance Sentiment

Sentiments overview associated with events and the stock performance.

86%

13%

Positive

Negative

304 out of 352
events present

46 out of 352
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support
Price

$670.21

Resistance
Price

$604.12

Current Price Range

$738.31

Show methods +

Latest Analyst Actions

Overall Wall Street Rating

95%

Buy

Hold

Sell

Consensus Rating

STRONG BUY

21

1

0

Date

Action

Rating

Firm

Feb 05, 2026

Price Target Raised

Buy

Freedom Capital

Jan 30, 2026

Reiterate

Buy

Stifel

Jan 26, 2026

Upgrade

Buy

Roth

Jan 21, 2026

Price Target Raised

Buy

BofA

Jan 21, 2026

Reiterate

Buy

Truist Securities

Jan 21, 2026

Upgrade

Buy

META Stock IQ

Login to unlock Meta Platforms (META) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Target Price

Login to display

Stock Insights

Strengths

META Rewards

Earnings are forecast to grow

META Rewards

Upgraded on attractively valued

META Rewards

Trading below its fair value

META Rewards

Outperform the market

META Latest Analysis

Whats Going On With Meta Platforms Stock Thursday?. META) stock is trading down in Thursday’.s regular trading extending losses to 9.13% over the past five days.The decline appears connected to broader weakness across major indexes. The Nasdaq-100 fell 1.32% to 24561 while the S&.P 500 dropped 1.04% to 6810.Meta’.s current weakness contrasts with its post-earnings performance following fourth-quarter results released January 29. Shares surged 9.24% to $730.50 that day after the comp

Thu Feb 5, 2026

$670.21 | +0.18%

Momentum

Will Meta Platforms Stock Plunge in 2026? 1 Warning and 1 Reason to Be Optimistic.. Key PointsMeta shares dipped in 2018 and 2022 so a fall in 2026 would line up with recent trends.

Thu Feb 5, 2026

$670.21 | +0.18%

Momentum

FDA Accepts Summit Therapeutics (SMMT) BLA For Ivonescimab In NSCLC With November 14 PDUFA Date Following Positive Phase III Data. Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the stocks that should double by 2030. On January 29 Summit Therapeutics announced that the US FDA accepted its BLA (Biologics License Application) for ivonescimab used in combination with chemotherapy. The treatment targets patients with EGFR-mutated locally advanced or metastatic non-squamous NSCLC (non-small cell lu

Thu Feb 5, 2026

$670.21 | +0.18%

Activity

Meta Platforms (META) Reports Strong Quarterly Results on Advertising Momentum. Meta Platforms Inc. (NASDAQ:META) is one of the 10 Buzzing AI Stocks on Market Radar. On February 3 Freedom Capital Markets analyst Saken Ismailov raised the price target on the stock to $825.00 (from $800.00) while maintaining a Buy rating. The rating affirmation follows Metas fourth-quarter 2025 results. The tech giant reported earnings that topped estimates and [….]

Thu Feb 5, 2026

$670.21 | +0.18%

Earnings

Rating

Despite Nearing a $2 Trillion Market Cap Meta Platforms Just Missed a Golden Opportunity. Key PointsThe Magnificent Seven -- led by Facebook parent Meta Platforms in 2026 -- have done most of the heavy lifting on Wall Street.

Thu Feb 5, 2026

$670.21 | +0.18%

Potential

Notable Wednesday Option Activity: META HOOD APP. Among the underlying components of the S&.P 500 index we saw noteworthy options trading volume today in Meta Platforms Inc (Symbol: META) where a total of 353162 contracts have traded so far representing approximately 35.3 million underlying shares. That amounts to about

Wed Feb 4, 2026

$668.99 | -3.28%

Momentum

Too Much Artificial Intelligence (AI) Capex? Not for Meta CEO Mark Zuckerberg Who Is Full Steam Ahead Much to the Markets Delight. Key PointsMeta Platforms recently unveiled capex guidance that was higher than Wall Street analysts expected.

Wed Feb 4, 2026

$668.99 | -3.28%

Momentum

Discover META Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of META. We're here to help you make informed investment decisions today.

FIND US ON

Receive our META Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

META Stock trends

META Stock performance

META Stock analysis

META investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing META

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing META

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

META Stock Analysis & IQ Rating | Meta Platforms

META Stock IQ

META Target Price

META Analysts Opinion

META Street Sentiment

META Risk Level

META Performance Sentiment

Key Price Levels

Analyst Consensus

Explore our META Stock insights

Receive our META Daily Alerts

META Street Sentiment

META Risk Level

Key Price Levels

Latest Analyst Actions

Discover META Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of META. We're here to help you make informed investment decisions today.

Receive our META Daily Alerts

META Alerts